NCT05716737 Exploring Radiotherapy of Temporomandibular Joint Arthritis
| NCT ID | NCT05716737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Arthritis of Temporomandibular Joint |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2023-07-07 |
| Primary Completion | 2024-07-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2023-07-07 with a primary completion date of 2024-07-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
With this pilot study, the acute side effects and potential pain relieve after radiotherapy (RT) of the temporomandibular joint (TMJ) are prospectively recorded. For this purpose, the symptoms of the jaw joint arthrosis/arthritis are recorded using a symptom-oriented questionnaire and the numeric rating scale for pain assessment. Furthermore, it is examined whether the irradiation is feasible.
Eligibility Criteria
Inclusion Criteria: * TMJ arthritis * diagnosed by a surgeon for oral and maxillofacial surgery or a dentist Exclusion Criteria: * Previous irradiation in the TMJ area * Age below 50 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05716737 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 100 Years, studying Arthritis of Temporomandibular Joint. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05716737 currently recruiting?
Yes, NCT05716737 is actively recruiting participants. Contact the research team at Cora.waldstein@meduniwien.ac.at for enrollment information.
Where is the NCT05716737 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT05716737 clinical trial?
NCT05716737 is sponsored by Medical University of Vienna. The trial plans to enroll 10 participants.